Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma

SUMMARY

N/A

COH Protocol Number : 15126

ClinicalTrials.gov Number : NCT01728805

Principal Investigator : Querfeld, Christiane M.D., Ph.D

Sponsor : Kyowa Hakko Kirin Pharma, Inc.

BRIEF ELIGIBILITY CRITERIA :

Eligible Ages : >=18

Gender : Either

Minimum Performance Status : ECOG/SWOG:1

Treatment Intent : Non-Adjuvant treatment

Prior Chemotherapy :

Brain Metastases :

Measurable Disease :